Kevin Guest, CEO of USANA Health Sciences (USNA), has demonstrated a consistent pattern of selling activity in the company’s stock over the past several years, with no recorded purchases. According to SEC Form 4 filings, Guest has executed 28 transactions totaling $1.85 million in sales since 2024, all involving USNA shares. His most significant single sale occurred on March 11, 2024, when he disposed of shares worth $539,539. Smaller but repeated sales followed in February 2025 and February 2026, with transactions typically clustered over consecutive days—such as February 6-8, 2025, when he sold $161,168, $85,697, and $148,376 worth of stock, respectively. A similar pattern emerged in February 2026, with sales of $114,062, $59,666, and $40,012 within three days.
The filings indicate that Guest’s transactions are primarily coded as "F" (dispositions under Rule 16b-3), suggesting they may be part of prearranged trading plans. While no buys are recorded, the regularity of sales—particularly in February of each year—points to a structured divestment strategy rather than opportunistic selling. The absence of any acquisition activity reinforces a clear directional bias toward reducing his stake in USNA over time. The most recent sale, on February 27, 2026, amounted to $71,618, continuing the trend of periodic, methodical disposals.
AI-assisted summary